BioCentury
ARTICLE | Clinical News

Nonoxynol-9 Novasome: Began Phase I trial

February 1, 1999 8:00 AM UTC

Novavax Inc. (NOX), Columbia, Md. Product: Nonoxynol-9 Novasome Business: Drug delivery, Reproductive Therapeutic category: Cytotoxic Target: Cellular membranes Description: Liposomal vaginal spermici...